Human protein tyrosine phosphatase 1B inhibitors: QSAR by genetic function approximation

References

• Defronzo RA. Pathogenesis of type 2 diabetes: Metabolic and molecular implications for identifying diabetic genes. Diabet Rev 1997; 5: 177–267
   Google Scholar
• Blaskovich MA, Kim HO. Recent discovery and development of protein tyrosine phosphatase inhibitors. Exp Opin Ther Patent 2002; 12: 871–905
   Web of Science ®Google Scholar
• Byon JCH, Kusari J, Kusari AB. Protein–tyrosine phosphatase-1B acts as a negative regulator of Insulin signal transduction. Mol Cell Biochem 1998; 182: 101–108
   PubMed Web of Science ®Google Scholar
• Elchelby M, Payette P, Michalisyn E, Cromlish W, Collinschan CC, Ramachandran C, Gresser MJ, Tremblay ML, Kennedy BP. Structure of protein tyrosine phosphatase 1B in complex with inhibitors bearing two phosphotyrosine mimetics. Science 1999; 283: 1544–1548
   PubMedGoogle Scholar
• Elizabeth AH, Nigel L. Protein tyrosine phosphatase 1B inhibitors for the treatment of type 2 diabetes and obesity; recent advances. Cur Opin Invest Drugs 2003; 4: 1179–1189
   PubMedGoogle Scholar
• Rogers D, Hopfinger AJ. Application of genetic function approximation to quantitative structure-activity relationships and quantitative structure-property relationships. J Chem Inf Comput Sci. 1994; 34: 854–866
   Google Scholar
• Shi LM, Fan Y, Myers TG, O'Connor PM, Paull KD, Friend SH, Weinstein JN. Mining the NCI anticancer drug discovery databases: Genetic function approximation for the QSAR study of anticancer ellipticine analogues. J Chem Inf Comput Sci 1998; 38: 189–199
   PubMedGoogle Scholar
• Venkatarangan P, Hopfinger AJ. Prediction of ligand-receptor binding thermodynamics by free energy force field three-dimensional quantitative structure-activity relationship analysis: Applications to a set of glucose analogue inhibitors of glycogen phosphorylase. J Med Chem 1999; 42: 2169–2179
   PubMed Web of Science ®Google Scholar
• Tokarski JS, Hopfinger AJ. Constructing protein models for ligand-receptor binding thermodynamic simulations: An application to a set of peptidometic renin inhibitors. J Chem Inf Comput Sci 1997; 37: 779–791
   PubMedGoogle Scholar
• Tokarski JS, Hopfinger AJ. Prediction of ligand-receptor binding thermodynamics by free energy force field (FEFF) 3D-QSAR analysis: Application to a set of peptidometic renin inhibitors. J Chem Inf Comput Sci 1997; 37: 792–811
   PubMedGoogle Scholar
• Hahn M, Rogers D. Receptor surface models. 2 application to quantitative structure-activity relationships studies. J Med Chem 1995; 38: 2091–2102
   PubMed Web of Science ®Google Scholar
• Hopfinger AJ, Kawayami Y. QSAR analysis of a set of benzothiopyranoindazole anti-cancer analogs based upon their DNA intercalation properties as determined by molecular dynamics simulation. Anticancer Drug Des 1992; 7: 203–217
   PubMedGoogle Scholar
• Kawakami Y, Inoue A, Kawai T, Wakita M, Sugimoto H, Hopfinger AJ. The rationale for E2020 as a potent acetylcholinesterase inhibitor. Bioorgan Med Chem 1996; 4: 1429–1449
   PubMed Web of Science ®Google Scholar
• Gokhale VM, Kulkarni VM. Understanding the antifungal activity of terbinafine analogues using quantitative structure–activity relationship (QSAR) models. Bioorgan Med Chem 2000; 8: 2487–2499
   PubMed Web of Science ®Google Scholar
• Karki RG, Kulkarni VM. Three-dimensional quantitative structure–activity relationship (3D-QSAR) of 3-aryloxazolidin-2-one antibacterials. Bioorgan Med Chem 2001; 9: 3153–3160
   PubMed Web of Science ®Google Scholar
• Makhija MT, Kulkarni VM. QSAR of HIV-1 integrase inhibitors by genetic function approximation method. Bioorgan Med Chem 2002; 10: 1483–1497
   PubMed Web of Science ®Google Scholar
• Vadlamudi SM, Kulkarni VM. 3D-QSAR of protein tyrosine phosphatase 1B inhibitors by genetic function approximation. Internet Electron. J Mol Des 2003; 3: 586–609
   Google Scholar
• Murthy VS, Kulkarni VM. Molecular modeling of protein tyrosine phosphatase 1B (PTP 1B) inhibitors. Bioorg Med Chem 2002; 10: 897–906
   PubMed Web of Science ®Google Scholar
• Kharkar PS, Desai B, Varu B, Loriya R, Naliyapara Y, Gaveria H, Shah A, Kulkarni VM. Three-dimensional quantitative structure-activity relationship of 1, 4-dihydropyridines as antitubercular agents. J Med Chem 2002; 45: 4858–4867
   PubMed Web of Science ®Google Scholar
• Shim YS, Kim KC, Chi DY, Lee KH, Cho H. Formylchromone derivatives as a novel class of protein tyrosine phosphatase 1B inhibitors. Bioorgan Med Chem Lett 2003; 13: 2561–2563
   PubMed Web of Science ®Google Scholar
• Shim YS, Kim KC, Lee KA, Shrestha S, Lee KH, Kim CK, Cho H. Formylchromone derivatives as irreversible and selective inhibitors of human protein tyrosine phosphatase 1B. Kinetic and modeling studies. Bioorgan Med Chem 2005; 13: 1325–1332
   PubMed Web of Science ®Google Scholar
• Cerius2 Version 4.10 is available from Molecular Simulations Inc.: 9685, Onton Road, San Diego CA, 92121, USA.
   Google Scholar
• Rappe AK, Goddard WA, III. Charge equilibration for molecular dynamics simulations. J Phys Chem 1991; 95: 3358–3363
   Web of Science ®Google Scholar
• Rappe AK, Casewit CJ, Colwell KS, Goddard GA, Skiff WM. Application of a universal force field to organic molecule. J Am Chem Soc 1992; 114: 10024–10035
   Web of Science ®Google Scholar
• Hopfinger AJ. A QSAR investigation fo dihydrofolate reductase inhibition by Baker triazines based upon molecular shape analysis. J Am Chem Soc 1980; 102: 7196–7206
   Web of Science ®Google Scholar
• Mayer D, Naylor CI, Motoc I, Marhsall G. A unique geometry of the active site of angiotensin converting enzyme consistent with structure-activity studies. J Comput Aided Mol Design 1987; 1: 3–16
   PubMedGoogle Scholar
• Waller CL, Opera TL, Giollitti A, Marshal GR. Three-dimensional QSAR of human immunodeficiency virus (1) protease inhibitors. 1. A CoMFA study employing experimentally-determined alignment rules. J Med Chem 1993; 36: 4152–4160
   PubMed Web of Science ®Google Scholar
• Crammer RD, III, Bunce JD, Patterson DE. Cross-validation, boot strapping and partial Least squares compared with multiple regressions in conventional QSAR studies. Quant Struct Act Relat 1998; 7: 18–25
   Google Scholar